AMN Healthcare Services, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 6, 2026, reporting third-quarter revenue of $717,272 thousand and net income of $33,394 thousand.

Key Highlights

  • Quarterly revenue: $717,272 thousand for the three months ended September 30, 2026, compared with $634,496 thousand in the same period of 2025, according to the filing.
  • Net income: $33,394 thousand for Q3 2026, up from $29,288 thousand in Q3 2025, as reported in the condensed consolidated statements.
  • Nine-month revenue: $2,768,870 thousand for the nine months ended September 30, 2026, versus $1,982,204 thousand for the same period in 2025.
  • Diluted EPS: $0.83 per share for Q3 2026, compared with $0.76 for Q3 2025; nine-month diluted EPS was $2.93 versus $(2.29) in 2025.
  • Cash and equivalents: $255,978 thousand as of September 30, 2026, up from $33,972 thousand at December 31, 2025.
  • Total assets: $2,292,968 thousand at September 30, 2026, compared with $2,094,107 thousand at December 31, 2025.
  • Shares outstanding: 38,562,904 shares of common stock as of November 3, 2026, per the filing cover page.

AMN Healthcare's Financial Position and Operating Results for the September 2026 Quarter

According to the filing, AMN Healthcare Services, Inc. (NYSE:AMN) reported revenue of $717,272 thousand for the three months ended September 30, 2026, an increase from $634,496 thousand in the comparable prior-year quarter. Gross profit for the third quarter of 2026 was $229,123 thousand, compared with $184,412 thousand in Q3 2025. Income from operations was $50,517 thousand versus $47,618 thousand in the prior-year period. The company disclosed net income of $33,394 thousand for Q3 2026, compared with $29,288 thousand for Q3 2025.

For the nine months ended September 30, 2026, the filing reported revenue of $2,768,870 thousand and net income of $116,720 thousand, a significant shift from a net loss of $88,006 thousand in the same nine-month period of 2025. The company noted that the prior-year nine-month period included a goodwill impairment loss of $109,515 thousand and a long-lived assets impairment loss of $18,262 thousand, as well as a gain on sale of disposal group of $39,180 thousand, none of which recurred in the 2026 period.

The condensed consolidated balance sheet as of September 30, 2026, reflected total assets of $2,292,968 thousand and total liabilities of $1,517,958 thousand, leaving total stockholders' equity of $775,010 thousand. Cash and cash equivalents grew to $255,978 thousand from $33,972 thousand at December 31, 2025. Notes payable, net of unamortized fees and premium, stood at $743,370 thousand, while the revolving credit facility balance was $0 at September 30, 2026, down from $25,000 thousand at December 31, 2025. Goodwill was reported at $758,999 thousand, and intangible assets, net, at $233,809 thousand.

What Was Disclosed

AMN Healthcare filed its quarterly report covering the period ended September 30, 2026, disclosing revenue, earnings, balance sheet data, and equity activity for the third quarter and first nine months of 2026, with comparisons to the corresponding 2025 periods.